Zhang Hong-Da, Tang Min, Zhang Jing-Tao
Arrhythmia Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China.
J Cardiovasc Dev Dis. 2022 Oct 29;9(11):370. doi: 10.3390/jcdd9110370.
Secondary bradyarrhythmias in hypertrophic cardiomyopathy (HCM) have been extensively reported. The prevalence and characteristics of primary bradyarrhythmias in HCM have yet to be investigated.
We retrospectively enrolled 101 consecutive patients with HCM who were referred to the arrhythmia center from May 2010 to October 2020. The clinical features of patients with bradyarrhythmias were analyzed.
Twenty-nine (28.7%) patients had primary bradyarrhythmias, and six (5.9%) patients had secondary third-degree atrioventricular block (AVB). Of the 29 patients, 17 (58.6%) had sinus node dysfunction (SND), 14 (48.3%) had AVB, and two (6.9%) had both SND and AVB. The median age was 62 years old, and 69% were male. Six (20.7%) patients had left ventricular obstructive outflow tract obstruction, 15 (51.7%) had a history of syncope, and one (3.4%) had a family history of HCM. Most patients (86.2%) had New York Heart Association functional class I or II, and the median left ventricular ejection fraction was 63%. A total of 22 patients received pacemaker implantation, including 17 (77.3%) dual-chamber pacing, four (18.2%) single-chamber ventricular pacing, and one (4.5%) cardiac resynchronization therapy.
Primary bradyarrhythmias need to be evaluated in HCM patients with arrhythmia-related symptoms. Patients with HCM might need pacemaker implantation for primary bradyarrhythmias.
肥厚型心肌病(HCM)继发缓慢性心律失常已有广泛报道。HCM 原发性缓慢性心律失常的患病率及特征尚未得到研究。
我们回顾性纳入了 2010 年 5 月至 2020 年 10 月连续转诊至心律失常中心的 101 例 HCM 患者。分析了缓慢性心律失常患者的临床特征。
29 例(28.7%)患者存在原发性缓慢性心律失常,6 例(5.9%)患者存在继发性三度房室传导阻滞(AVB)。在这 29 例患者中,17 例(58.6%)有窦房结功能障碍(SND),14 例(48.3%)有 AVB,2 例(6.9%)同时有 SND 和 AVB。中位年龄为 62 岁,69%为男性。6 例(20.7%)患者有左心室流出道梗阻,15 例(51.7%)有晕厥史,1 例(3.4%)有 HCM 家族史。大多数患者(86.2%)纽约心脏协会心功能分级为 I 级或 II 级,左心室射血分数中位数为 63%。共有 22 例患者接受了起搏器植入,其中 17 例(77.3%)为双腔起搏,4 例(18.2%)为单腔心室起搏,1 例(4.5%)为心脏再同步治疗。
对于有与心律失常相关症状的 HCM 患者,需要评估原发性缓慢性心律失常。HCM 患者可能因原发性缓慢性心律失常而需要植入起搏器。